These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1516988)

  • 1. Blood pressure after three different forms of correction of anemia in hemodialysis.
    Pascual J; Teruel JL; Marcén R; Liaño F; Ortuño J
    Int J Artif Organs; 1992 Jul; 15(7):393-6. PubMed ID: 1516988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R; Obialo CI; Rothstein M
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M; Umezu M; Nagano M; Tagawa H
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
    Ballal SH; Domoto DT; Polack DC; Marciulonis P; Martin KJ
    Am J Kidney Dis; 1991 Jan; 17(1):29-33. PubMed ID: 1986567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
    Berns JS; Rudnick MR; Cohen RM
    Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Canadian Erythropoietin Study Group.
    Am J Nephrol; 1991; 11(1):23-6. PubMed ID: 2048574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
    Baldamus CA; Steffen AM; Brunner R; Pollok M
    Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of blood pressure changes during recombinant human erythropoietin therapy.
    Levin N
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin and hypertension].
    Frei U; Nonnast-Daniel B; Koch KM
    Klin Wochenschr; 1988 Sep; 66(18):914-9. PubMed ID: 3054276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen versus erythropoietin for the treatment of anaemia of pre-dialysis chronic kidney disease.
    Paul AK; Latif ZA; Iqbal S; Amin F; Shefin SM; Ashrafuzzaman SM
    Mymensingh Med J; 2012 Jan; 21(1):125-8. PubMed ID: 22314467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor effect of recombinant human erythropoietin: results of home blood pressure measurements in hemodialysis patients.
    Imai Y; Fujikura Y; Minami N; Munakata M; Hashimoto J; Sakuma H; Watanabe N; Nishiyama A; Misawa S; Sekino H
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):51-6. PubMed ID: 8107309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of erythropoietin and anemia correction.
    Vaziri ND
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):633-7. PubMed ID: 11496057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
    Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
    Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy.
    Kaupke CJ; Kim S; Vaziri ND
    J Am Soc Nephrol; 1994 May; 4(11):1874-8. PubMed ID: 7919137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
    Campos A; Garin EH
    Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.